Trinity Biotech
TRIB
19 hedge funds and large institutions have $2.95M invested in Trinity Biotech in 2024 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 4 increasing their positions, 2 reducing their positions, and 3 closing their positions.
100% more repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 2
0.01% less ownership
Funds ownership: 0.05% → 0.04% (-0.01%)
5% less funds holding
Funds holding: 20 → 19 (-1)
33% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 3
48% less capital invested
Capital invested by funds: $5.67M → $2.95M (-$2.73M)
58% less call options, than puts
Call options by funds: $5K | Put options by funds: $12K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
HF
HRT Financial
New York
|
+$76.6K |
| 2 |
HAIM
Hunter Associates Investment Management
Pittsburgh,
Pennsylvania
|
+$58.8K |
| 3 |
VF
Virtu Financial
New York
|
+$7.91K |
| 4 |
SIC
SJS Investment Consulting
Sylvania,
Ohio
|
+$4.53K |
| 5 |
RhumbLine Advisers
Boston,
Massachusetts
|
+$3.24K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Acadian Asset Management
Boston,
Massachusetts
|
-$68.2K |
| 2 |
Renaissance Technologies
New York
|
-$34.5K |
| 3 |
RWMG
Redwood Wealth Management Group
Medford,
New Jersey
|
-$4.32K |
| 4 |
GRP
Global Retirement Partners
San Rafael,
California
|
-$1.7K |
| 5 |
Simplex Trading
Chicago,
Illinois
|
-$68 |
TRIB Hedge Fund Activity: Q3 2024 in Review
19 of the 6,978 institutional investors tracked by Wall St. Rank reported a position in Trinity Biotech (TRIB) for Q3 2024, worth a combined $2.95M — down 48% from $5.67M a quarter earlier.
Sellers outnumbered buyers: 3 funds closed out of TRIB and 2 opened new positions — a net loss of 1 holder — while 2 trimmed existing stakes and 4 added.
The largest buyer was HRT Financial, opening a new position worth an estimated $76.6K. The largest seller was Acadian Asset Management, cutting an estimated $68.2K.
- 19 institutional investors held Trinity Biotech (TRIB) as of Q3 2024, down from 20 in Q2 2024.
- Funds reported $2.95M of Trinity Biotech stock for Q3 2024, down 48% quarter-over-quarter.
- 2 funds opened new Trinity Biotech positions in Q3 2024 and 3 closed out, a net change of -1 holder.
- The largest Trinity Biotech buyer in Q3 2024 was HRT Financial, an estimated $76.6K added.
- The largest Trinity Biotech seller in Q3 2024 was Acadian Asset Management, an estimated $68.2K sold.
Based on aggregated 13F filings for Q3 2024.